Management of dyslipidemia in HIV-infected patients
- PMID: 22216062
- PMCID: PMC3249059
- DOI: 10.2217/clp.11.25
Management of dyslipidemia in HIV-infected patients
Abstract
Antiretroviral therapy has dramatically increased survival for HIV-infected individuals. As this population lives longer, coronary heart disease has become an important comorbid condition. Dyslipidemia in HIV-infected individuals is a complex condition, with multiple contributing factors including the HIV virus itself, individual genetic characteristics and antiretroviral therapy-induced metabolic changes. Effective management of dyslipidemia in this population is essential to reduce cardiovascular risk but presents multiple challenges due to interactions between antiretroviral therapy agents and lipid-lowering medications.
Similar articles
-
Coronary heart disease risk, dyslipidemia, and management in HIV-infected persons.HIV Clin Trials. 2004 Nov-Dec;5(6):416-33. doi: 10.1310/P07M-HNT8-L08G-5TKU. HIV Clin Trials. 2004. PMID: 15682355 Review.
-
Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort.Open AIDS J. 2008;2:26-38. doi: 10.2174/1874613600802010026. Epub 2008 Mar 24. Open AIDS J. 2008. PMID: 18923695 Free PMC article.
-
Management of metabolic complications and cardiovascular risk in HIV-infected patients.AIDS Rev. 2010 Oct-Dec;12(4):231-41. AIDS Rev. 2010. PMID: 21179187 Review.
-
[HIV infection, antiretroviral therapy, and endothelium].Herz. 2005 Sep;30(6):472-80. doi: 10.1007/s00059-005-2740-3. Herz. 2005. PMID: 16170677 Review. German.
-
Dyslipidemia and lipid management in HIV-infected patients.Curr Opin Endocrinol Diabetes Obes. 2011 Apr;18(2):144-7. doi: 10.1097/MED.0b013e328344556e. Curr Opin Endocrinol Diabetes Obes. 2011. PMID: 21297466 Free PMC article. Review.
Cited by
-
Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES.AIDS Res Hum Retroviruses. 2013 Feb;29(2):350-8. doi: 10.1089/aid.2012.0278. Epub 2012 Dec 5. AIDS Res Hum Retroviruses. 2013. PMID: 23039030 Free PMC article. Clinical Trial.
-
Subclinical Atherosclerosis Is Associated with Discrepancies in BAFF and APRIL Levels and Altered Breg Potential of Precursor-like Marginal Zone B-Cells in Long-Term HIV Treated Individuals.Vaccines (Basel). 2022 Dec 30;11(1):81. doi: 10.3390/vaccines11010081. Vaccines (Basel). 2022. PMID: 36679926 Free PMC article.
-
The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population.BMC Public Health. 2014 Mar 7;14:236. doi: 10.1186/1471-2458-14-236. BMC Public Health. 2014. PMID: 24606888 Free PMC article.
-
Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects.AIDS Res Ther. 2013 Dec 13;10(1):32. doi: 10.1186/1742-6405-10-32. AIDS Res Ther. 2013. PMID: 24330597 Free PMC article.
-
Apolipoprotein E genetic variation, atherogenic index and cardiovascular disease risk assessment in an African population: An analysis of HIV and malaria patients in Ghana.PLoS One. 2023 May 3;18(5):e0284697. doi: 10.1371/journal.pone.0284697. eCollection 2023. PLoS One. 2023. PMID: 37134097 Free PMC article.
References
Bibliography
-
- Friis-Moller N, Reiss P, Sabin C, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356(17):1723–1735. - PubMed
-
- Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocr Metabo. 1992;74(5):1045–1052. - PubMed
-
- Klein DHL, Quesenberry C, Silverberg M, Horberg M, Sidney S. Hospitalizations for CHD and MI among northern California HIV+ and HIV− men: changes in practice and Framingham risk scores. Presented at: 13th Conference on Retroviruses and Opportunistic Infections; Denver, CO, USA. 5–8 February 2006.
-
- Obel N, Thomsen H, Kronborg G, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis. 2007;44(12):1625–1631. - PubMed
Website
-
- National Cholesterol Education Program. Third report on the expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). 2002 (Update 2004) [Accessed 29 November 2010]; www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf.
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials